Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C1ZQ
|
||||
| Former ID |
DIB015568
|
||||
| Drug Name |
Estrogen receptor beta modulators
|
||||
| Synonyms |
IDDBCP245397
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [552016] | ||
| Company |
GlaxoSmithKline plc
|
||||
| Canonical SMILES |
O=S(=O)(N1C2(CCCCC2)C=C(c2ccccc12)C)c1ccc(cc1)O
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | Modulator | [543899] | |
| KEGG Pathway | Estrogen signaling pathway | ||||
| Prolactin signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.